Covered recipient · General Payments record
ARMAAN GURAYA
General Payments · PY2023–2024
$1,294.50
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $987.12 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $324.75 | 10 |
| UCB, Inc. | $248.64 | 2 |
| Lilly USA, LLC | $145.50 | 7 |
| GENZYME CORPORATION | $103.19 | 1 |
| Blueprint Medicines Corporation | $55.36 | 2 |
| Dermavant Sciences, Inc. | $51.38 | 3 |
| Regeneron Healthcare Solutions, Inc. | $29.99 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $14.28 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268195 | CMS |
| Amgen Inc. | $18.87 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268197 | CMS |
| Amgen Inc. | $36.86 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268193 | CMS |
| Amgen Inc. | $23.18 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268199 | CMS |
| Amgen Inc. | $22.78 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268201 | CMS |
| Amgen Inc. | $7.98 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268203 | CMS |
| Amgen Inc. | $10.34 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268205 | CMS |
| Amgen Inc. | $146.24 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268207 | CMS |
| Amgen Inc. | $19.14 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268209 | CMS |
| Amgen Inc. | $25.08 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117268211 | CMS |
| Blueprint Medicines Corporation | $23.18 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147445894 | CMS |
| Blueprint Medicines Corporation | $32.18 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147445978 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $28.31 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117915257 | CMS |
| Dermavant Sciences, Inc. | $15.09 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127873945 | CMS |
| Dermavant Sciences, Inc. | $21.32 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127873949 | CMS |
| Dermavant Sciences, Inc. | $14.97 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127873952 | CMS |
| GENZYME CORPORATION | $103.19 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139989927 | CMS |
| Lilly USA, LLC | $26.70 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051879 | CMS |
| Lilly USA, LLC | $22.36 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136000613 | CMS |
| Lilly USA, LLC | $8.35 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136051877 | CMS |
| Lilly USA, LLC | $26.51 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136063962 | CMS |
| Lilly USA, LLC | $22.54 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136056278 | CMS |
| Lilly USA, LLC | $10.09 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136047945 | CMS |
| Lilly USA, LLC | $28.95 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136053780 | CMS |
| Regeneron Healthcare Solutions, Inc. | $29.99 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114062129 | CMS |
| UCB, Inc. | $123.91 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143239801 | CMS |
| UCB, Inc. | $124.73 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143239805 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.